Hopp til hovedinnholdet

KAPITTEL 21
Referanser

Allen, J. P., D. F. Reinert and R. J. Volk (2001). "The alcohol use disorders identification test: an aid to recognition of alcohol problems in primary care patients." Prev.Med. 33(5): 428-433.

Allsop, D. J., N. Lintzeris, J. Copeland, A. Dunlop and I. S. McGregor (2015). "Cannabinoid replacement therapy (CRT): Nabiximols (Sativex) as a novel treatment for cannabis withdrawal." Clin Pharmacol Ther 97(6): 571-574.

Allsop, D. J., M. M. Norberg, J. Copeland, S. Fu and A. J. Budney (2011). "The Cannabis Withdrawal Scale development: patterns and predictors of cannabis withdrawal and distress." Drug Alcohol Depend 119(1-2): 123-129.

Alvik, A., O. O. Aalen and R. Lindemann (2013). "Early Fetal Binge Alcohol Exposure Predicts High Behavioral Symptom Scores in 5.5-Year-Old Children." Alcohol Clin.Exp.Res.

Alvik, A., S. Heyerdahl, T. Haldorsen and R. Lindemann (2006). "Alcohol use before and during pregnancy: a population-based study." Acta Obstet.Gynecol.Scand. 85(11): 1292-1298.

Alvik, A., A. M. Torgersen, O. O. Aalen and R. Lindemann (2011). "Binge alcohol exposure once a week in early pregnancy predicts temperament and sleeping problems in the infant." Early Hum.Dev. 87(12): 827-833.

Alwyn, T., B. John, R. J. Hodgson and C. J. Phillips (2004). "The addition of a psychological intervention to a home detoxification programme." Alcohol Alcohol 39(6): 536-541.

Amato, L., M. Davoli, S. Minozzi, R. Ali and M. Ferri (2005). "Methadone at tapered doses for the management of opioid withdrawal." Cochrane.Database.Syst.Rev.(3): CD003409.

Amato, L., S. Minozzi, M. Davoli and S. Vecchi (2011). "Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification." Cochrane.Database.Syst.Rev. 9: CD005031.

Amato, L., S. Minozzi, S. Vecchi and M. Davoli (2010). "Benzodiazepines for alcohol withdrawal." Cochrane.Database.Syst.Rev.(3): CD005063.

Amundsen, E. J. (2015). "Narkotikautløste dødsfall."

Amundsen, E. J., I. Lund, A. L. Bretteville-Jensen, A. Skretting, J. Rise and S. Nordlund (2010). Hva er misbruk og avhengighet? Betegnelser, begreper og omfang. SIRUS-rapporter.

Andersen, S. N. and K. Skullerud (1999). "Hypoxic/ischaemic brain damage, especially pallidal lesions, in heroin addicts." Forensic Sci.Int. 102(1): 51-59.

Antonovsky, A. (1996). "The salutogenic model as a theory to guide health promotion." Health Promotion International 11(1): 11-18.

Araujo, L., P. Goldberg, J. Eyma, S. Madhusoodanan, D. D. Buff, K. Shamim and R. Brenner (1996). "The effect of anxiety and depression on completion/withdrawal status in patients admitted to substance abuse detoxification program." J.Subst.Abuse Treat. 13(1): 61-66.

Ashton, H. (2005). "The diagnosis and management of benzodiazepine dependence." Curr.Opin.Psychiatry 18(3): 249-255.

Backmund, M., K. Meyer, D. Eichenlaub and C. G. Schutz (2001). "Predictors for completing an inpatient detoxification program among intravenous heroin users, methadone substituted and codeine substituted patients." Drug Alcohol Depend. 64(2): 173-180.

Bahr, R. (2009). Aktivitetshåndboken: fysisk aktivitet i forebygging og behandling, Helsedirektoratet.

Beattie, M. C. (2001). "Meta-Analysis of social relationships and posttreatment drinking outcomes: comparison of relationship structure, function and quality." J Stud.Alcohol 62(4): 518-527.

Behnke, M. and V. C. Smith (2013). "Prenatal substance abuse: short- and long-term effects on the exposed fetus." Pediatrics 131(3): e1009-1024.

Bell, J. and R. Collins (2011). "Gamma-butyrolactone (GBL) dependence and withdrawal." Addiction 106(2): 442-447.

Berman, A. H., H. Bergman, T. Palmstierna and F. Schlyter (2005). "Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample." Eur.Addict.Res. 11(1): 22-31.

Berman, A. H., H. Bergman, T. Palmstierna and F. Schlyter (2007). DUDIT. The Drug Use Disorder Identification Test. Manual.

Berman, A. H., T. Palmstierna, H. Kallmen and H. Bergman (2007). "The self-report Drug Use Disorders Identification Test: Extended (DUDIT-E): reliability, validity, and motivational index." J.Subst.Abuse Treat. 32(4): 357-369.

Bhanushali, G. K., G. Jain, H. Fatima, L. J. Leisch and D. Thornley-Brown (2013). "AKI associated with synthetic cannabinoids: a case series." Clin J Am Soc Nephrol 8(4): 523-526.

Binswanger, I. A., P. J. Blatchford, S. R. Mueller and M. F. Stern (2013). "Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009." Ann Intern Med 159(9): 592-600.

Biong, S., B. Karlsson and T. Svensson (2008). "Metaphors of a shifting sense of self in men recovering from substance abuse and suicidal behaviour." Journal of Psychiatric Nursing and Mental Health Services 46(4): 35-41.

Biong, S. and E. Ravndal (2007). "Young mens' experiences of living with abuse and suicidal behavior." Int.J.Qualitative Studies on Health and Well-being 2(4): 246-259.

Biong, S. and T. Svensson (2009). "Bridging the gaps: Experiencing and preventing life-threatening heroin overdoses in men in Oslo." Int.J.Qualitative Studies on Health and Well-being 4(2): 94-105.

Blinick, G., R. C. Wallach and E. Jerez (1969). "Pregnancy in narcotics addicts treated by medical withdrawal. The methadone detoxification program." Am J Obstet Gynecol 105(7): 997-1003.

Blondell, R. D., L. M. Frydrych, U. Jaanimagi, L. Ashrafioun, G. G. Homish, E. M. Foschio and H. L.

Bashaw (2011). "A randomized trial of two behavioral interventions to improve outcomes following inpatient detoxification for alcohol dependence." J Addict Dis 30(2): 136-148.

Bogstrand, S. T., P. T. Normann, I. Rossow, M. Larsen, J. Morland and O. Ekeberg (2011). "Prevalence of alcohol and other substances of abuse among injured patients in a Norwegian emergency department." Drug Alcohol Depend.

Bretteville-Jensen, A. L. and E. J. Amundsen (2006). Omfanget av sprøytemisbruk i Norge. Oslo, Statens institutt for rusmiddelforskning. SIRUS-rapport 5/2006.

Brugal, M. T., G. Barrio, L. F. De, E. Regidor, L. Royuela and J. M. Suelves (2002). "Factors associated with non-fatal heroin overdose: assessing the effect of frequency and route of heroin administration." Addiction 97(3): 319-327.

Brvar, M. (2005). "S100B protein in heroin overdose: A pilot study." Critical Care 9(1): 290.

Budney, A. J. and J. R. Hughes (2006). "The cannabis withdrawal syndrome." Curr Opin Psychiatry 19(3): 233-238.

Budney, A. J., B. A. Moore, R. G. Vandrey and J. R. Hughes (2003). "The time course and significance of cannabis withdrawal." J Abnorm Psychol 112(3): 393-402.

Burns, E., R. Gray and L. A. Smith (2010). "Brief screening questionnaires to identify problem drinking during pregnancy: a systematic review." Addiction 105(4): 601-614.

Buser, G. L., R. R. Gerona, B. Z. Horowitz, K. P. Vian, M. L. Troxell, R. G. Hendrickson, D. C. Houghton, D. Rozansky, S. W. Su and R. F. Leman (2014). "Acute kidney injury associated with smoking synthetic cannabinoid." Clin Toxicol (Phila) 52(7): 664-673.

Cantwell, B. and A. J. McBride (1998). "Self detoxication by amphetamine dependent patients: a pilot study." Drug Alcohol Depend 49(2): 157-163.

Clayton, A. H. (2005). "Blog Archives Complementary and Alternative Medicine." Primary psychiatry 12(8): 37-44.

Condelli, W. S., M. A. Koch and B. Fletcher (2000). "Treatment refusal/attrition among adults randomly assigned to programs at a drug treatment campus The New Jersey Substance Abuse Treatment Campus, Seacaucus, NJ." Journal of Substance Abuse Treatment 18(4): 395-407.

Connaughton, J. F., D. Reeser, J. Schut and L. P. Finnegan (1977). "Perinatal addiction: outcome and management." Am J Obstet Gynecol 129(6): 679-686.

Cramer, V. (2014). Prosjektrapport 2014-1: Forekomst av psyksike lidelser hos domfelte i norske fengsler, Oslo univrsitetssykehus, Kompetansesenter for sikkerhets-, fengsels- og rettspsykiatri Helseregion Sør-Øst.

Cui, C.-L., L.-Z. Wu and F. Luo (2008). "Acupuncture for the treatment of drug addiction." Neurochemical research 33(10): 2013-2022.

Dahlgren, L. and A. Willander (1989). "Are special treatment facilities for female alcoholics needed? A controlled 2-year follow-up study from a specialized female unit (EWA) versus a mixed male/female treatment facility." Alcohol Clin.Exp.Res. 13(4): 499-504.

Dahlgren, L. and A. Willander (1989). "[A study of abusers at the EWA unit: women not treated for their alcohol problems have an increased mortality rate]." Lakartidningen 86(20): 1898-1900.

Dalsbø, T. S., A; Høie,B (2009). Er kjønnssegregert behandling det beste for rusavhengige kvinner? Systematisk litteratursøk med sortert referanseliste, Nasjonalt kunnskapssenter for helsetjenesten.

Darke, S. and J. Ross (2002). "Suicide among heroin users: rates, risk factors and methods." Addiction 97(11): 1383-1394.

Darke, S., A. Williamson, J. Ross, K. L. Mills, A. Havard and M. Teesson (2007). "Patterns of nonfatal heroin overdose over a 3-year period: findings from the Australian treatment outcome study." J.Urban.Health 84(2): 283-291.

Day, E., J. Ison and J. Strang (2010). "Inpatient versus other settings for detoxification for opioid dependence." Cochrane.Database.Syst.Rev.(2): CD004580.

Day, E. and J. Strang (2011). "Outpatient versus inpatient opioid detoxification: a randomized controlled trial." J.Subst.Abuse Treat. 40(1): 56-66.

Denis, C., M. Fatseas, E. Lavie and M. Auriacombe (2006). "Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings." Cochrane.Database.Syst.Rev.(3): CD005194.

DeVido, J., O. Bogunovic and R. D. Weiss (2015). "Alcohol use disorders in pregnancy." Harv Rev Psychiatry 23(2): 112-121.

Diehl, A., L. Ulmer, J. Mutschler and H. Herre (2010). "Why is disulfiram superior to acomprosat in the routine clinical setting? A retrospective long-term study in 353 alcohol-dependent patients." Alcohol and alcoholism 45(3): 271-277.

Dolovich, L. R., A. Addis, J. M. Vaillancourt, J. D. Power, G. Koren and T. R. Einarson (1998). "Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies." Bmj 317(7162): 839-843.

Doran, C. M., M. Shanahan, J. Bell and A. Gibson (2004). "A cost-effectiveness analysis of buprenorphine-assisted heroin withdrawal." Drug Alcohol Rev. 23(2): 171-175.

Duncan, E., C. Best and S. Hagen (2010). "Shared decision making interventions for people with mental health conditions." Cochrane Database Syst Rev 1.

Dunn, K. E., S. C. Sigmon, E. C. Strain, S. H. Heil and S. T. Higgins (2011). "The association between outpatient buprenorphine detoxification duration and clinical treatment outcomes: a review." Drug Alcohol Depend. 119(1-2): 1-9.

Ebright, J. R. and B. Pieper (2002). "Skin and soft tissue infections in injection drug users." Infect.Dis.Clin.North Am. 16(3): 697-712.

Enato, E., M. Moretti and G. Koren (2011). "The fetal safety of benzodiazepines: an updated meta-analysis." J Obstet Gynaecol Can 33(1): 46-48.

Every-Palmer, S. (2011). "Synthetic cannabinoid JWH-018 and psychosis: an explorative study." Drug Alcohol Depend 117(2-3): 152-157.

Ewing, J. A. (1984). "Detecting alcoholism. The CAGE questionnaire." JAMA 252(14): 1905-1907.

Eyer, F., M. Schreckenberg, D. Hecht and K. Adorjan (2011). "Treatment.Carbamazepin and valproat as adjuncts in the treatment of alchol withdrawal syndrome: A retrospective cohort study." Alcohol and alcoholism 46(2): 177-184.

Eyer, F., T. Schuster, N. Felgenhauer, R. Pfab, T. Strubel, B. Saugel and T. Zilker (2011). "Risk assessment of moderate to severe alcohol withdrawal--predictors for seizures and delirium tremens in the course of withdrawal." Alcohol Alcohol 46(4): 427-433.

Fatovich, D. M., A. Bartu, G. Davis, J. Atrie and F. F. Daly (2010). "Morbidity associated with heroin overdose presentations to an emergency department: a 10-year record linkage study." Emerg.Med.Australas. 22(3): 240-245.

Fatseas, M., E. Lavie, C. Denis, P. Franques-Reneric, J. Tignol and M. Auriacombe (2006). "[Benzodiazepine withdrawal in subjects on opiate substitution treatment]." Presse Med. 35(4 Pt 1): 599-606.

Fiellin, D. A., M. C. Reid and P. G. O'Connor (2000). "Screening for alcohol problems in primary care: a systematic review." Arch.Intern.Med. 160(13): 1977-1989.

Finnegan, L. P., D. S. Reeser and J. F. Connaughton, Jr. (1977). "The effects of maternal drug dependence on neonatal mortality." Drug Alcohol Depend 2(2): 131-140.

Franken, I. H. and V. M. Hendriks (1999). "Predicting outcome of inpatient detoxification of substance abusers." Psychiatr.Serv. 50(6): 813-817.

Furuholmen, D. and A. S. Andresen (2007). Fellesskapet som metode, Cappelen akademisk.

Gibson, A. E., C. M. Doran, J. R. Bell, A. Ryan and N. Lintzeris (2003). "A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trial." Med.J.Aust. 179(1): 38-42.

Gjersing, L., S. Biong, E. Ravndal, H. Waal, J. Bramness and T. Clausen (2011). Dødelige overdoser i Oslo 2006-2008.

Gjestad, R., J. Franck, S. Lindberg and B. Haver (2011). "Early Treatment for Women with Alcohol Addiction (EWA) reduces mortality: a randomized controlled trial with long-term register follow-up." Alcohol Alcohol 46(2): 170-176.

Glyngdal, P. and K. Hansen (1997). "Benzodaizepinmisbru hos heroinmisbrugere i København." Videnskap og praksis: 6523-6527.

Gossop, M. (1990). "The development of a Short Opiate Withdrawal Scale (SOWS)." Addict.Behav. 15(5): 487-490.

Gossop, M., M. Battersby and J. Strang (1991). "Self-detoxification by opiate addicts. A preliminary investigation." Br.J.Psychiatry 159: 208-212.

Gossop, M., L. Green, G. Phillips and B. Bradley (1989). "Lapse, relapse and survival among opiate addicts after treatment. A prospective follow-up study." Br.J.Psychiatry 154: 348-353.

Gossop, M., A. Johns and L. Green (1986). "Opiate withdrawal: inpatient versus outpatient programmes and preferred versus random assignment to treatment." Br.Med.J.(Clin.Res.Ed) 293(6539): 103-104.

Gowing, L., R. Ali and J. M. White (2009). "Buprenorphine for the management of opioid withdrawal." Cochrane.Database.Syst.Rev.(3): CD002025.

Gowing, L., R. Ali and J. M. White (2010). "Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal." Cochrane.Database.Syst.Rev.(1): CD002022.

Gråwe, R. and T. Ruud (2006). Rus og psykiske lidelser i psykisk helsevern for voksne.

Gunderson, J. (1978). "Defining the therapeutic process in psychiatric milieus." Psychiatry 41: 327-335.

Hasin, D. S., K. M. Keyes, D. Alderson, S. Wang, E. Aharonovich and B. F. Grant (2008). "Cannabis withdrawal in the United States: results from NESARC." J Clin Psychiatry 69(9): 1354-1363.

Haugsgjerd, S., P. Jensen, B. Karlsson and J. A. Løkke (2009). Perspektiver på psykisk lidelse - å forstå, beskrive og behandle. Oslo, Gyldendal akademisk.

Heberlein, A., L. Leggio, D. Stichtenoth and T. Hillemacher (2012). "The treatment of alcohol and opioid dependence in pregnant women." Curr Opin Psychiatry 25(6): 559-564.

Helland, A. and S. Skjotskift (2008). "[Drug treatment of alcohol withdrawal]." Tidsskr.Nor Laegeforen. 128(10): 1182-1184.

Hermanns-Clausen, M., S. Kneisel, B. Szabo and V. Auwarter (2013). "Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings." Addiction 108(3): 534-544.

Herrestad, H. and S. Biong (2010). "Relational hopes: A study of the lived experience of hope in some patients hospitalized for intentional self-har,." Int.J of Qualitative Studies on Health and Well-being 5: 1-9.

Hill, M. and K. Reed (2013). "Pregnancy, breast-feeding, and marijuana: a review article." Obstet Gynecol Surv 68(10): 710-718.

Hobbesland, Å. (2006). Undersøkelse av avgiftningsbehandling ved seks avgiftningsavdelinger i Helseregion Sør.

Hodt-Billington, C. (2012). Veileder for utvikling av kunnskapsbaserte retningslinjer. Helsedirektoratet. Oslo, Helsedirektoratet. IS-1870.

Hoffman, R. S. and G. L. Weinhouse (2013). Management of moderate and severe alcohol withdrawal syndromes. UpToDate.

Holbrook, A. M., R. Crowther, A. Lotter, C. Cheng and D. King (1999). "Diagnosis and management of acute alcohol withdrawal." CMAJ. 160(5): 675-680.

Holbrook, A. M., R. Crowther, A. Lotter, C. Cheng and D. King (1999). "Meta-analysis of benzodiazepine use in the treatment of acute alcohol withdrawal." CMAJ. 160(5): 649-655.

Horspool, M. J., N. Seivewright, C. J. Armitage and N. Mathers (2008). "Post-treatment outcomes of buprenorphine detoxification in community settings: a systematic review." Eur.Addict.Res. 14(4): 179-185.

Huizink, A. C. (2014). "Prenatal cannabis exposure and infant outcomes: overview of studies." Prog Neuropsychopharmacol Biol Psychiatry 52: 45-52.

Jones, H. E., K. Kaltenbach, S. H. Heil, S. M. Stine, M. G. Coyle, A. M. Arria, K. E. O'Grady, P. Selby, P. R. Martin, L. Jansson and G. Fischer (2012). "Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus?" J.Matern.Fetal Neonatal Med. 25(7): 1197-1201.

Jordan, J. B. (2006). "Acupuncture treatment for opiate addiction: a systematic review." Journal of Substance Abuse Treatment 30(4): 309-314.

Kandall, S. R., S. Albin, J. Lowinson, B. Berle, A. I. Eidelman and L. M. Gartner (1976). "Differential effects of maternal heroin and methadone use on birthweight." Pediatrics 58(5): 681-685.

Kaskutas, L. A., L. Zhang, M. T. French and J. Witbrodt (2005). "Women's programs versus mixed‐gender day treatment: results from a randomized study." Addiction 100(1): 60-69.

Kirkengen, A. L. (2000). "Innskrevet i kroppen." Tidsskr.Nor Laegeforen. 13: 120-124.

Kluwer, W. (2009). Principles of Addiction Medicine, Lippincott, Williams & Willems.

Kristensen, O., T. Lolandsmo, A. Isaksen, J. K. Vederhus and T. Clausen (2006). "Treatment of polydrug-using opiate dependents during withdrawal: towards a standardisation of treatment." BMC.Psychiatry 6: 54.

Kunoe, N., P. Lobmaier, H. Ngo and G. K. Hulse (2012). "Injectable and implantable sustained release naltrexone in the treatment of opioid addiction." Br.J.Clin.Pharmacol.

Kunoe, N., P. Lobmaier, J. K. Vederhus, B. Hjerkinn, M. Gossop, S. Hegstad, O. Kristensen and H. Waal (2010). "Challenges to antagonist blockade during sustained-release naltrexone treatment." Addiction 105(9): 1633-1639.

Kunoe, N., P. Lobmaier, J. K. Vederhus, B. Hjerkinn, S. Hegstad, M. Gossop, O. Kristensen and H. Waal (2009). "Naltrexone implants after in-patient treatment for opioid dependence: randomised controlled trial." Br.J.Psychiatry 194(6): 541-546.

Kunoe, N., P. Lobmaier, J. K. Vederhus, B. Hjerkinn, S. Hegstad, M. Gossop, O. Kristensen and H. Waal (2010). "Retention in naltrexone implant treatment for opioid dependence." Drug Alcohol Depend. 111(1-2): 166-169.

Lambie, D., R. Johnson, M. Vijayasenan and E. Whiteside (1980). "Sodium valproate in the treatment of the alcohol withdrawal syndrome." Australasian Psychiatry 14(3): 213-215.

Landheim, A. S., K. Bakken and P. Vaglum (2003). "Gender differences in the prevalence of symptom disorders and personality disorders among poly-substance abusers and pure alcoholics. Substance abusers treated in two counties in Norway." Eur.Addict.Res. 9(1): 8-17.

Leach, D. and P. Oliver (2011). "Drug-related death following release from prison: a brief review of the literature with recommendations for practice." Curr Drug Abuse Rev 4(4): 292-297.

Lineberry, T. W. and J. M. Bostwick (2006). "Methamphetamine abuse: a perfect storm of complications." Mayo Clin Proc 81(1): 77-84.

Lingford-Hughes, A. R., S. Welch, L. Peters and D. J. Nutt (2012). "BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP." J.Psychopharmacol. 26(7): 899-952.

Lippestad, J.-W. and S. Steihaug (2015). Evaluering av Rusakuttmottaket ved Oslo Universitetssykehus HF, SINTEF Teknologi og samfunn. Avdeling Helse.

Liu, T.-t., J. Shi, D. H. Epstein, Y.-p. Bao and L. Lu (2009). "A meta-analysis of acupuncture combined with opioid receptor agonists for treatment of opiate-withdrawal symptoms." Cellular and molecular neurobiology 29(4): 449-454.

Lobmaier, P., M. Gossop, H. Waal and J. Bramness (2010). "The pharmacological treatment of opioid addiction--a clinical perspective." Eur.J.Clin.Pharmacol. 66(6): 537-545.

Lobmaier, P., H. Kornor, N. Kunoe and A. Bjorndal (2008). "Sustained-release naltrexone for opioid dependence." Cochrane.Database.Syst.Rev.(2): CD006140.

Lobmaier, P. P., N. Kunoe, M. Gossop, T. Katevoll and H. Waal (2010). "Naltrexone implants compared to methadone: outcomes six months after prison release." Eur.Addict.Res. 16(3): 139-145.

Lobmaier, P. P., N. Kunoe, M. Gossop and H. Waal (2011). "Naltrexone depot formulations for opioid and alcohol dependence: a systematic review." CNS.Neurosci.Ther. 17(6): 629-636.

Macfarlane, V. and G. Christie (2015). "Synthetic cannabinoid withdrawal: a new demand on detoxification services." Drug Alcohol Rev 34(2): 147-153.

Mancino, M. J., B. W. Gentry, Z. Feldman, J. Mendelson and A. Oliveto (2011). "Characterizing methamphetamine withdrawal in recently abstinent methamphetamine users: a pilot field study." Am J Drug Alcohol Abuse 37(2): 131-136.

Manning, M. A. and H. Eugene Hoyme (2007). "Fetal alcohol spectrum disorders: a practical clinical approach to diagnosis." Neurosci Biobehav Rev 31(2): 230-238.

Manning, V., D. Best, N. Faulkner, E. Titherington, A. Morinan, F. Keaney, M. Gossop and J. Strang (2012). "Does active referral by a doctor or 12-Step peer improve 12-Step meeting attendance? Results from a pilot randomised control trial." Drug Alcohol Depend 126(1-2): 131-137.

Marshall, K., L. Gowing, R. Ali and B. Le Foll (2014). "Pharmacotherapies for cannabis dependence." Cochrane Database Syst Rev 12: Cd008940.

Mattick, R. P. and W. Hall (1996). "Are detoxification programmes effective?" Lancet 347(8994): 97-100.

Mattson, S. N., N. Crocker and T. T. Nguyen (2011). "Fetal alcohol spectrum disorders: neuropsychological and behavioral features." Neuropsychol Rev 21(2): 81-101.

Mayo-Smith, M. F. (1997). "Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal." JAMA 278(2): 144-151.

McCarthy, J. J. (2012). "Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus?" J Matern Fetal Neonatal Med 25(2): 109-112.

McGregor, C., M. Srisurapanont, J. Jittiwutikarn, S. Laobhripatr, T. Wongtan and J. M. White (2005). "The nature, time course and severity of methamphetamine withdrawal." Addiction 100(9): 1320-1329.

McKeon, A., M. A. Frye and N. Delanty (2008). "The alcohol withdrawal syndrome." J.Neurol.Neurosurg.Psychiatry 79(8): 854-862.

Mellingen, S. (2012). A woman left lonely. En studie av kvinner og alkohol, avhengigher og relasjon i behandling. Rusmidler og rusmiddelbruk

K. Humerfelt and H. Sagvaag. Bergen, Høgskolen i Bergen og Stiftelsen Bergensklinikkene.

Meneses-Gaya, C., J. A. Crippa, A. W. Zuardi, S. R. Loureiro, J. E. Hallak, C. Trzesniak, J. P. Machado de Sousa, M. H. Chagas, R. M. Souza and R. Martin-Santos (2010). "The fast alcohol screening test (FAST) is as good as the AUDIT to screen alcohol use disorders." Subst.Use.Misuse. 45(10): 1542-1557.

Meneses-Gaya, C., A. W. Zuardi, S. R. Loureiro, J. E. Hallak, C. Trzesniak, J. M. de Azevedo Marques, J. P. Machado-de-Sousa, M. H. Chagas, R. M. Souza and J. A. Crippa (2010). "Is the full version of the AUDIT really necessary? Study of the validity and internal construct of its abbreviated versions." Alcohol Clin.Exp.Res. 34(8): 1417-1424.

Metz, T. D. and E. H. Stickrath (2015). "Marijuana use in pregnancy and lactation: a review of the evidence." Am J Obstet Gynecol.

Miller, S. D. and B. L. Duncan (2004). "The outcome and session rating scales: Administration and scoring manual." Chicago: Institute for the Study of Therapeutic Change.

Minozzi, S., L. Amato, S. Vecchi and M. Davoli (2010). "Anticonvulsants for alcohol withdrawal." Cochrane.Database.Syst.Rev.(3): CD005064.

Minozzi, S., L. Amato, S. Vecchi, M. Davoli, U. Kirchmayer and A. Verster (2011). "Oral naltrexone maintenance treatment for opioid dependence." Cochrane.Database.Syst.Rev.(2): CD001333.

Mir, A., A. Obafemi, A. Young and C. Kane (2011). "Myocardial infarction associated with use of the synthetic cannabinoid K2." Pediatrics 128(6): e1622-1627.

Moe, A. (2008). "Fra å sette arr på det til å sette ord på det: "Det er ikke vondt å kutte, men det er jævlig vondt å la være"." Suicidologi 3(13): 24-25.

Moe, T. M., E.W. (2011). Fysisk aktivitet i psykisk helsearbeid. Psykisk helsearbeid - mer enn medisiner og samtaleterapi. E. W. Borge. Bergen, Fagbokforlaget.

Moller, L. F., S. Matic, B. J. van den Bergh, K. Moloney, P. Hayton and A. Gatherer (2010). "Acute drug-related mortality of people recently released from prisons." Public Health 124(11): 637-639.

Moner, S. E. (1996). "Acupuncture and addiction treatment." Journal of addictive diseases 15(3): 79-100.

Moraes, E., G. M. Campos, N. B. Figlie, R. Laranjeira and M. B. Ferraz (2010). "Cost-effectiveness of home visits in the outpatient treatment of patients with alcohol dependence." Eur.Addict.Res. 16(2): 69-77.

Mørch-Johnsen, G. H., J. A. Andersen and G. Høiseth (2015). Rapport om konsekvenser for fosteret/barnet ved bruk av rusmidler/avhengighetsskapende legemidler i svangerskapet. Oslo, Nasjonalt folkehelseinstitutt.

Nacca, N., D. Vatti, R. Sullivan, P. Sud, M. Su and J. Marraffa (2013). "The synthetic cannabinoid withdrawal syndrome." J Addict Med 7(4): 296-298.

Naeye, R. L., W. Blanc, W. Leblanc and M. A. Khatamee (1973). "Fetal complications of maternal heroin addiction: abnormal growth, infections, and episodes of stress." J Pediatr 83(6): 1055-1061.

Nebb, A.-H. L., R-M; Wangsberg,S (2010). Klient- og resultatstyrt praksis. Erfaringer fra ruspoliklinikken UNN, Kompetansesenter rus Nord-Norge.

Newton, T. F., A. D. Kalechstein, S. Duran, N. Vansluis and W. Ling (2004). "Methamphetamine abstinence syndrome: preliminary findings." Am J Addict 13(3): 248-255.

NICE (2008). Drug misuse: Opioid detoxification.

NICE (2010). Delirium: diagnosis, prevention and management.

NICE (2011). Alcohol-use disorders. Diagnosis, assessment and management of harmful drinking and alcohol dependence.

Nilsen, E. M., L. Bachs, T. Bjørner, G. Høiseth, J. Johnsen, A. L. Ørbeck, H. Waal, S. S. Ormstad, H. Kornør, E. J. Paulsen and B. Hoffmann (2007). Benzodiazepiner i behandlingen av personer med rusmiddelproblemer. Medisinsk metodevurdering.

Noble, A., D. Best, L. H. Man, M. Gossop and J. Stang (2002). "Self-detoxification attempts among methadone maintenance patients: what methods and what success?" Addict.Behav. 27(4): 575-584.

Nordlie, E., T. Voyvik and O. G. Aasland (2002). "[Treatment offered to drug addicts]." Tidsskr.Nor Laegeforen. 122(25): 2455-2457.

Ntais, C., E. Pakos, P. Kyzas and J. P. Ioannidis (2005). "Benzodiazepines for alcohol withdrawal." Cochrane Database Syst Rev(3): Cd005063.

Oei, J., M. E. Abdel-Latif, R. Clark, F. Craig and K. Lui (2010). "Short-term outcomes of mothers and infants exposed to antenatal amphetamines." Arch Dis Child Fetal Neonatal Ed 95(1): F36-41.

Oei, J. L., A. Kingsbury, A. Dhawan, L. Burns, J. M. Feller, S. Clews, J. Falconer and M. E. Abdel-Latif (2012). "Amphetamines, the pregnant woman and her children: a review." J Perinatol 32(10): 737-747.

Overå, M. (2013). Hekta på musikk, Norges musikkhøgskole.

PAFFMUA (2011). Miljøterapi, en modell for tenkning, holdning og handling, Stiftelsen Psykiatrisk Opplysning.

Pallesen, S., C. S. Andreassen, S. M. Jensen, O. Jøsendal, S. Wadsworth and H. S. Pettersen (2014). "Anabole-androgene steroider - en oversikt." Tidsskrift for Norsk Psykologforening 51.

Parr, J. M., D. J. Kavanagh, L. Cahill, G. Mitchell and Y. R. McD (2009). "Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis." Addiction 104(1): 13-24.

Pilling, S., J. Strang and C. Gerada (2007). "Psychosocial interventions and opioid detoxification for drug misuse: summary of NICE guidance." BMJ 335(7612): 203-205.

Psychoyos, D. and K. Y. Vinod (2013). "Marijuana, Spice 'herbal high', and early neural development: implications for rescheduling and legalization." Drug Test Anal 5(1): 27-45.

Raistrick, D., D. West, O. Finnegan, G. Thistlethwaite, R. Brearley and J. Banbery (2005). "A comparison of buprenorphine and lofexidine for community opiate detoxification: results from a randomized controlled trial." Addiction 100(12): 1860-1867.

Ravndal, E. and E. J. Amundsen (2010). "Mortality among drug users after discharge from inpatient treatment: an 8-year prospective study." Drug Alcohol Depend 108(1-2): 65-69.

Reinert, D. F. and J. P. Allen (2002). "The Alcohol Use Disorders Identification Test (AUDIT): a review of recent research." Alcohol Clin.Exp.Res. 26(2): 272-279.

Rementeria, J. L. and N. N. Nunag (1973). "Narcotic withdrawal in pregnancy: stillbirth incidence with a case report." Am J Obstet Gynecol 116(8): 1152-1156.

Reoux, J. P. and K. Miller (2000). "Routine hospital alcohol detoxification practice compared to symptom triggered management with an Objective Withdrawal Scale (CIWA-Ar)." Am.J.Addict. 9(2): 135-144.

Riley, E. P., M. A. Infante and K. R. Warren (2011). "Fetal alcohol spectrum disorders: an overview." Neuropsychol Rev 21(2): 73-80.

Ringerrike, T., H. Kornor, I. Harboe and M. Klemp (2009). Effekt av tiltak for å avslutte legemiddelavhengighet.

Rootman, D. B., R. Mustard, V. Kalia and N. Ahmed (2007). "Perceptions and realities of testing for alcohol and other drugs in trauma patients." Journal of Trauma-Injury Infection & Critical Care 63(6): 1370-1373.

Rosner, S., A. Hackl-Herrwerth, S. Leucht, S. Vecchi, M. Srisurapanont and M. Soyka (2010). "Opioid antagonists for alcohol dependence." Cochrane.Database.Syst.Rev.(12): CD001867.

Ross, E. J., D. L. Graham, K. M. Money and G. D. Stanwood (2015). "Developmental consequences of fetal exposure to drugs: what we know and what we still must learn." Neuropsychopharmacology 40(1): 61-87.

Rossow, I. and G. Lauritzen (1999). "Balancing on the edge of death: suicide attempts and life-threatening overdoses among drug addicts." Addiction 94(2): 209-219.

Russell, M., S. S. Martier, R. J. Sokol, P. Mudar, S. Bottoms, S. Jacobson and J. Jacobson (1994). "Screening for pregnancy risk-drinking." Alcohol Clin.Exp.Res. 18(5): 1156-1161.

Saeland, M., M. Haugen, F. L. Eriksen, A. Smehaugen, M. Wandel, T. Bohmer and A. Oshaug (2009). "Living as a drug addict in Oslo, Norway--a study focusing on nutrition and health." Public Health Nutr 12(5): 630-636.

Saeland, M., M. Haugen, F. L. Eriksen, M. Wandel, A. Smehaugen, T. Bohmer and A. Oshaug (2011). "High sugar consumption and poor nutrient intake among drug addicts in Oslo, Norway." Br J Nutr 105(4): 618-624.

Sagoe, D., J. McVeigh, A. Bjornebekk, M. S. Essilfie, C. S. Andreassen and S. Pallesen (2015). "Polypharmacy among anabolic-androgenic steroid users: a descriptive metasynthesis." Subst Abuse Treat Prev Policy 10: 12.

Sannibale, C., L. Fucito, D. O'Connor and K. Curry (2005). "Process evaluation of an out-patient detoxification service." Drug Alcohol Rev. 24(6): 475-481.

Saunders, J. B., O. G. Aasland, T. F. Babor, J. R. de la Fuente and M. Grant (1993). "Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II." Addiction 88(6): 791-804.

Schaefer, T. J. and J. W. Hafner (2013). "Are benzodiazepines effective for alcohol withdrawal?" Ann.Emerg.Med. 62(1): 34-35.

Schibbye, A. L. (1996). "Anerkjennelse; en terapeutisk intervensjon?" Tidsskrift for Norsk Psykologforening 33: 530-537.

Shoptaw, S. J., U. Kao, K. Heinzerling and W. Ling (2009). "Treatment for amphetamine withdrawal." Cochrane.Database.Syst.Rev.(2): CD003021.

Silins, E., C. Sannibale, S. Larney, A. Wodak and R. Mattick (2008). "Residential detoxification: essential for marginalised, severely alcohol- and drug-dependent individuals." Drug Alcohol Rev. 27(4): 414-419.

Skjellanger, A.-G., E. T. Deilkås and R. Sørensen (2014). Sluttrapport for pasientsikkerhetskampanjen i trygge hender 24-7. 2011-2013, Kunnskapssenteret.

Skjervheim, H. and A. Aarnes (1996). Deltakar og tilskodar og andre essays, Aschehoug.

Skjøtskift, S. (2015). Lommerus. En guide for helsepersonell til behandling av rusmedisinske problemstillinger, Avdeling for rusmedisin. Helse Bergen, Haukeland universitetssjukehus

Skrede, A., H. Munkvold, Ø. Watne and E. Martinsen (2006). "[Exercise contacts in the treatment of substance dependence and mental disorders]." Tidsskrift for den Norske laegeforening: tidsskrift for praktisk medicin, ny raekke 126(15): 1925-1927.

Skårderud, F. (2000). Sterk/svak, Aschehoug.

Skårderud, F., S. Haugsgjerd and Stãnicke (2010). Psykiatriboken. Sinn-kropp-samfunn. Oslo, Gyldendal Akademisk.

Skårderud, F. and B. Sommerfeldt (2013). Miljøterapiboken. Mentalisering som holdning og handling, Gyldendal.

Smedslund, G., R. C. Berg, K. T. Hammerstrom, A. Steiro, K. A. Leiknes, H. M. Dahl and K. Karlsen (2011). "Motivational interviewing for substance abuse." Cochrane.Database.Syst.Rev.(5): CD008063.

Specka, M., A. Buchholz, T. Kuhlmann, F. Rist and N. Scherbaum (2011). "Prediction of the outcome of inpatient opiate detoxification treatment: results from a multicenter study." Eur.Addict.Res. 17(4): 178-184.

Stade, B. C., C. Bailey, D. Dzendoletas, M. Sgro, T. Dowswell and D. Bennett (2009). "Psychological and/or educational interventions for reducing alcohol consumption in pregnant women and women planning pregnancy." Cochrane Database Syst Rev(2): Cd004228.

Startup, M., M. C. Jackson and S. Bendix (2002). "The concurrent validity of the Global Assessment of Functioning (GAF)." Br.J.Clin.Psychol. 41(Pt 4): 417-422.

Strang, J., I. Marks, S. Dawe, J. Powell, M. Gossop, D. Richards and J. Gray (1997). "Type of hospital setting and treatment outcome with heroin addicts. Results from a randomised trial." Br.J.Psychiatry 171: 335-339.

Strantz, I. H. and S. P. Welch (1995). "Postpartum women in outpatient drug abuse treatment: Correlates of retention/completion." Journal of Psychoactive Drugs 27(4): 357-373.

Strong, T., O. Sutherland and O. Ness (2011). "Considerations for a discourse of collaboration in counseling." Asia Pacific Journal of Counselling and Psychotherapy 2(1): 25-40.

Strøm, R., H. Munkvold, S. Skjøtskift, R. Høifødt and K. Tømmervik (2010). Hva er god akuttbehandling i TSB?

Strømfors, G. E.-G., M (2013). Jeg visste ikke at jeg kunne så mye. Praksisrefleksjoner på arbeidsplassen. Oslo.

Stuppaeck, C. H., C. Barnas, M. Falk, V. Guenther, M. Hummer, H. Oberbauer, R. Pycha, A. B. Whitworth and W. W. Fleischhacker (1994). "Assessment of the alcohol withdrawal syndrome--validity and reliability of the translated and modified Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-A)." Addiction 89(10): 1287-1292.

Sullivan, J. T., K. Sykora, J. Schneiderman, C. A. Naranjo and E. M. Sellers (1989). "Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar)." Br.J.Addict. 84(11): 1353-1357.

Sundfør, K.-O. (2012). "Fra bruker til erfaringskonsulent." Tidsskrift for psykisk helsearbeid 9(4): 366-369.

Suttie, M., T. Foroud, L. Wetherill, J. L. Jacobson, C. D. Molteno, E. M. Meintjes, H. E. Hoyme, N. Khaole, L. K. Robinson, E. P. Riley, S. W. Jacobson and P. Hammond (2013). "Facial dysmorphism across the fetal alcohol spectrum." Pediatrics 131(3): e779-e788.

Taylor, A. H. and M. H. Ussher (2005). "Effects of exercise on smoking cessation and coping with withdrawal symptoms and nicotine cravings." Exercise, health and mental health: Emerging relationships: 135-158.

Torjussen, E., H. L. Harwiss and I. A. Havnes (2014). Brukermedvirkning i TSB - en myte? TSB Skriftserie nr.1 2014. Oslo, Nasjonal kompetansetjeneste TSB.

Trulsson, K. and U.-C. Hedin (2004). "The role of social support when giving up drug abuse: a female perspective." International Jornal of Social Welfare 13: 145-157.

Tuv, S. S., M. C. Strand, R. Karinen, E. L. Oiestad, A. S. Christophersen and V. Vindenes (2012). "[Effect and occurrence of synthetic cannabinoids]." Tidsskr Nor Laegeforen 132(20): 2285-2288.

UpToDate. (2013, 2013). "Benzodiazepin poisoning and withdrawal." www.uptodate.com.

UpToDate. (2013, 2013). "Co-occurring anxiety disorders and substance use disorders: epidemiology, clinical manifestation and diagnosis."

UpToDate. (2013, 2013). "Dual diagnosis:severe mental illness and substance use disorders."

Vederhus, J.-K., S. E. Zemore, J. Rise, T. Clausen and M. Høie (2015). "Predicting patient post-detoxification engagement in 12-step groups with an extended version of the theory of planned behavior." Addiction Science & Clinical Practice 10(1): 15.

Vederhus, J. K., B. Hjerkinn and O. Kristensen (2011). "[Self-help groups for substance addicts]." Tidsskr.Nor Laegeforen. 131(12): 1204-1206.

Vederhus, J. K., O. Kristensen, A. Laudet and T. Clausen (2009). "Attitudes towards 12-step groups and referral practices in a 12-step naive treatment culture; a survey of addiction professionals in Norway." BMC.Health Serv.Res. 9: 147.

Vederhus, J. K., C. Timko, O. Kristensen and T. Clausen (2011). "The courage to change: patient perceptions of 12-Step fellowships." BMC.Health Serv.Res. 11: 339.

Vederhus, J. K., C. Timko, Ø. Kristensen, B. Hjemdahl and T. Clausen (2014). "Motivational intervention to enhance post‐detoxification 12‐Step group affiliation: a randomized controlled trial." Addiction 109(5): 766-773.

Voshaar, R. C., J. E. Couvee, A. J. van Balkom, P. G. Mulder and F. G. Zitman (2006). "Strategies for discontinuing long-term benzodiazepine use: meta-analysis." Br.J.Psychiatry 189: 213-220.

Waal, H., K. Bussesund, T. Clausen, A. Håseth and P. H. Lillevold (2014). Statusrapport 2014. Helseforetakene - et godt sted å være? Oslo, Senter for rus- og avhengighetsforskning, Universitetet i Oslo. Seraf rapport 1/2014.

Wallach, R. C., E. Jerez and G. Blinick (1975). "Comparison of pregnancies and births during methadone detoxification and maintenance." Pediatr Ann 4(7): 46-61.

Watten, R. and H. Waal (2001). Avrusning: Fra vilje til medisin. Avrusningstradisjonene i Norge belyst gjennom en forundersøkelse til ultrarask opioidavrusning (UROD).

Welle-Strand, G. K. (1998). Hvordan møte overdoseproblematikken på kort og lang sikt i Oslo kommune?

Welle-Strand, G. K., S. Skurtveit, H. E. Jones, H. Waal, B. Bakstad, L. Bjarko and E. Ravndal (2013). "Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009." Drug Alcohol Depend 127(1-3): 200-206.

Welle-Strand, G. K., S. Skurtveit, L. Tanum, H. Waal, B. Bakstad, L. Bjarko and E. Ravndal (2015). "Tapering from Methadone or Buprenorphine during Pregnancy: Maternal and Neonatal Outcomes in Norway 1996-2009." Eur Addict Res 21(5): 253-261.

Wesson, D. R. and W. Ling (2003). "The Clinical Opiate Withdrawal Scale (COWS)." J.Psychoactive Drugs 35(2): 253-259.

Wichmann, S., S. L. Nielsen, V. D. Siersma and L. S. Rasmussen (2013). "Risk factors for 48-hours mortality after prehospital treatment of opioid overdose." Emerg Med J 30(3): 223-225.

Wiese, J. G., M. G. Shlipak and W. S. Browner (2000). "The alcohol hangover." Ann.Intern.Med. 132(11): 897-902.

Wikner, B. N., C. O. Stiller, U. Bergman, C. Asker and B. Kallen (2007). "Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations." Pharmacoepidemiol Drug Saf 16(11): 1203-1210.

Williams, D. and A. J. McBride (1998). "The drug treatment of alcohol withdrawal symptoms: a systematic review." Alcohol Alcohol 33(2): 103-115.

Winstock, A. R. and M. J. Barratt (2013). "Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample." Drug Alcohol Depend 131(1-2): 106-111.

Wisløff, C., E. Haug, A. V. Becken, T. O. Aamo, R. Hobbesland, M. Koroma, B. H. Manger, F. Lauritzen, B. J. Vikesund and H. P. Aasen (2015). Håndbok. Anabole-androgene steroider. Kunnskap og veiledning i diagnostikk og behandling., Nasjonal kompetansetjeneste TSB, Oslo universitetssykehus.

Wright, T. E., R. Schuetter, J. Tellei and L. Sauvage (2015). "Methamphetamines and pregnancy outcomes." J Addict Med 9(2): 111-117.

Young, A. C., E. Schwarz, G. Medina, A. Obafemi, S. Y. Feng, C. Kane and K. Kleinschmidt (2012). "Cardiotoxicity associated with the synthetic cannabinoid, K9, with laboratory confirmation." Am J Emerg Med 30(7): 1320.e1325-1327.

Zelson, C., E. Rubio and E. Wasserman (1971). "Neonatal narcotic addiction: 10 year observation." Pediatrics 48(2): 178-189.

Zuspan, F. P., J. A. Gumpel, A. Mejia-Zelaya, J. Madden and R. Davis (1975). "Fetal stress from methadone withdrawal." Am J Obstet Gynecol 122(1): 43-46.

Zvosec, L. and S. Smith (2010). Gamma hydroxybutyrate (GHB) dependence and withdrawal. UpToDate.

Først publisert: 29. februar 2016 Sist faglig oppdatert: 13. mai 2016